Davis R M Inc Novartis Ag Transaction History

Davis R M Inc

$5.09 Billion
Q3 2024

A detailed history of Davis R M Inc transactions in Novartis Ag stock. As of the latest transaction made, Davis R M Inc holds 2,109 shares of NVS stock, worth $218,935. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,109

Previous 2,199 4.09%

Holding current value

$218,935

Previous $234,000 3.42%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$106.13 - $120.89 $9,551 - $10,880	-90 Reduced 4.09%	2,109 $242,000
Q2 2024 Aug 09, 2024	BUY	$92.57 - $107.37 $9,257 - $10,737	100 Added 4.76%	2,199 $234,000
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $23,817 - $27,117	-250 Reduced 10.64%	2,099 $203,000
Q4 2023 Feb 09, 2024	BUY	$92.27 - $101.54 $23,067 - $25,385	250 Added 11.91%	2,349 $237,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $198,838 - $220,667	2,099 New	2,099 $214,000
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $982 - $1,202	-13 Reduced 0.36%	3,559 $323,000
Q3 2022 Nov 08, 2022	BUY	$74.61 - $87.26 $4,327 - $5,061	58 Added 1.65%	3,572 $272,000
Q1 2022 May 05, 2022	SELL	$80.11 - $90.62 $40,055 - $45,310	-500 Reduced 12.46%	3,514 $308,000
Q4 2021 Feb 08, 2022	SELL	$79.7 - $88.13 $55,869 - $61,779	-701 Reduced 14.87%	4,014 $351,000
Q3 2021 Nov 08, 2021	BUY	$81.78 - $95.14 $8,259 - $9,609	101 Added 2.19%	4,715 $386,000
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $27,703 - $30,598	325 Added 7.58%	4,614 $421,000
Q1 2021 May 10, 2021	SELL	$83.5 - $98.47 $58,032 - $68,436	-695 Reduced 13.94%	4,289 $367,000
Q4 2020 Jan 27, 2021	BUY	$78.07 - $94.43 $174,954 - $211,617	2,241 Added 81.7%	4,984 $471,000
Q3 2020 Dec 01, 2020	BUY	$82.14 - $91.0 $22,588 - $25,025	275 Added 11.14%	2,743 $239,000
Q2 2020 Jul 20, 2020	BUY	$80.93 - $91.1 $199,735 - $224,834	2,468 New	2,468 $216,000
Q1 2020 Apr 24, 2020	SELL	$70.67 - $99.01 $167,770 - $235,049	-2,374 Closed	0 $0
Q4 2019 Jan 23, 2020	SELL	$84.35 - $95.37 $4,554 - $5,149	-54 Reduced 2.22%	2,374 $225,000
Q3 2019 Oct 24, 2019	BUY	$85.54 - $94.26 $11,376 - $12,536	133 Added 5.8%	2,428 $211,000
Q1 2019 Apr 29, 2019	SELL	$75.32 - $86.15 $19,206 - $21,968	-255 Reduced 10.0%	2,295 $221,000
Q4 2018 Jan 18, 2019	BUY	$73.66 - $82.02 $16,499 - $18,372	224 Added 9.63%	2,550 $219,000
Q3 2018 Oct 17, 2018	BUY	$66.94 - $77.43 $155,702 - $180,102	2,326 New	2,326 $200,000
Q2 2018 Jul 19, 2018	SELL	$64.91 - $73.36 $170,388 - $192,570	-2,625 Closed	0 $0
Q1 2018 Apr 19, 2018	BUY	$70.39 - $84.15 $7,039 - $8,415	100 Added 3.96%	2,625 $212,000
Q3 2017 Oct 24, 2017	BUY	$74.14 - $77.27 $187,203 - $195,106	2,525	2,525 $217,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davis R M Inc, based on Form 13F filings with the SEC.

News

Stay updated on Davis R M Inc with notifications on news.

Account